Healthcare -
Biotechnology - NASDAQ - US
$ 9.5
0.849 %
$ 968 M
Market Cap
-1.74
P/E
NTLA - OTHER CURRENT LIABILITIES
Other Current Liabilities NTLA - Intellia Therapeutics, Inc.
67 M
LAST VALUE
39.99%
2 YEAR CAGR
44.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR